ERBB2 and breast carcinoma: Choi, W.J. et al. investigated the relationship between MRI features and tumor-infiltrating lymphocytes (TILs) in estrogen receptor (ER)-negative, HER2-positive breast cancer and found that certain MRI characteristics, such as lesion enhancement patterns, were significantly correlated with higher levels of TILs [16].